Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Two routes of administration for misoprostol in the treatment of incomplete abortion: a randomized clinical trial CONTRACEPTION Diop, A., Raghavan, S., Rakotovao, J., Comendant, R., Blumenthal, P. D., Winikoff, B. 2009; 79 (6): 456-462

Abstract

This study was conducted to compare the safety, effectiveness and acceptability of 400 mcg sublingual misoprostol and 600 mcg oral misoprostol for treatment of incomplete abortion.We used an open-label randomized controlled trial conducted from July 2005 to August 2006 in a large tertiary level maternity hospital in Antananarivo, Madagascar, and a large tertiary level hospital in Chisinau, Moldova. Three hundred consenting women seeking treatment for clinically diagnosed incomplete abortion with uterine size

View details for DOI 10.1016/j.contraception.2008.11.016

View details for Web of Science ID 000266343500011

View details for PubMedID 19442782